155 related articles for article (PubMed ID: 36047446)
1. Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines.
Cho CS; Jo DH; Kim JH; Kim JH
Mol Cells; 2022 Oct; 45(10):729-737. PubMed ID: 36047446
[TBL] [Abstract][Full Text] [Related]
2. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.
Zhou Z; Jiang H; Xia J; Zhang J
Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992
[TBL] [Abstract][Full Text] [Related]
4. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis.
Zhao H; Wan J; Zhu Y
Drug Des Devel Ther; 2020; 14():3417-3427. PubMed ID: 32904674
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis.
Wang Y; Xin D; Zhou L
Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644
[TBL] [Abstract][Full Text] [Related]
7. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.
Zhao F; Wang H; Kunda P; Chen X; Liu QL; Liu T
Oncol Rep; 2013 Sep; 30(3):1473-82. PubMed ID: 23818062
[TBL] [Abstract][Full Text] [Related]
8. L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.
Jo DH; Lee K; Kim JH; Jun HO; Kim Y; Cho YL; Yu YS; Min JK; Kim JH
Oncotarget; 2017 Feb; 8(9):15441-15452. PubMed ID: 28061460
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Int J Oncol; 2007 Sep; 31(3):585-92. PubMed ID: 17671685
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor impact on retinoblastoma progression and survival.
Cebulla CM; Jockovich ME; Piña Y; Boutrid H; Alegret A; Kulak A; Hackam AS; Bhattacharya SK; Feuer WJ; Murray TG
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5215-21. PubMed ID: 18614803
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inhibits growth, proliferation, and increases response to chemotherapy in retinoblastoma cells.
Yang Q; Tripathy A; Yu W; Eberhart CG; Asnaghi L
Exp Eye Res; 2017 Sep; 162():48-61. PubMed ID: 28689747
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Sreenivasan S; Krishnakumar S
Curr Eye Res; 2015; 40(11):1153-65. PubMed ID: 25495096
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑34a inhibits the proliferation and promotes the chemosensitivity of retinoblastoma cells by downregulating Notch1 expression.
Yin W; Gao F; Zhang S
Mol Med Rep; 2020 Aug; 22(2):1613-1620. PubMed ID: 32626991
[TBL] [Abstract][Full Text] [Related]
14. Panax notoginseng saponins induce apoptosis in retinoblastoma Y79 cells via the PI3K/AKT signalling pathway.
Liu J; Zhang C; Jia B; Dong K; Li M; Qiu D; Li L; Xu B; Sun S; Li C
Exp Eye Res; 2022 Mar; 216():108954. PubMed ID: 35074343
[TBL] [Abstract][Full Text] [Related]
15. Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma.
Leng T; Cebulla CM; Schefler AC; Murray TG
Retina; 2010 Apr; 30(4 Suppl):S66-8. PubMed ID: 20419851
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization analysis of newly established retinoblastoma cell lines of adherent growth compared with Y79 of nonadherent growth.
Kim JH; Kim JH; Yu YS; Kim DH; Kim YK; Kim KW
J Pediatr Hematol Oncol; 2008 Aug; 30(8):571-4. PubMed ID: 18799932
[TBL] [Abstract][Full Text] [Related]
17. lncRNA
Yang L; Zhang L; Lu L; Wang Y
DNA Cell Biol; 2020 Jan; 39(1):69-77. PubMed ID: 31702387
[TBL] [Abstract][Full Text] [Related]
18. RPL41 sensitizes retinoblastoma cells to chemotherapeutic drugs via ATF4 degradation.
Geng W; Ren J; Shi H; Qin F; Xu X; Xiao S; Jiao Y; Wang A
J Cell Physiol; 2021 Mar; 236(3):2214-2225. PubMed ID: 32783256
[TBL] [Abstract][Full Text] [Related]
19. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells.
Di Felice V; Lauricella M; Giuliano M; Emanuele S; Vento R; Tesoriere G
Int J Oncol; 1998 Aug; 13(2):225-32. PubMed ID: 9664115
[TBL] [Abstract][Full Text] [Related]
20. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
